BIOCON LTD. - 532523 - Announcement Under Regulation 30- Revised Intimation
Biocon Biologics Limited, a subsidiary of Biocon Limited, has divested the businesses in relation to its non-core branded formulations in India, to Eris Lifesciences Limited on a ''slump sale'' basis. BIOCON LTD. - 532523 - Announcement Under Regulation 30
Biocon Biologics Limited, a subsidiary of Biocon Limited has divested the businesses in relation to its non-core branded formulations in India to Eris Lifesciences Limited on a ''slump sale'' basis.
Eris Lifesciences to buy Biocon arm's derma, nephro units; Eris, Biocon shares in focus
Eris Lifesciences has signed a definitive agreement with Biocon Biologics to acquire its Branded Formulations' India (BFI) business units of nephrology and dermatology. BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release titled, "Biocon Ranked No. 8 Among Science Magazine''s Best Employers in Global Biotech and Pharma Sector" BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement regarding the Notice of Postal Ballot and Remote e-voting BIOCON LTD. - 532523 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Notice of Postal Ballot Movers & Shakers: Stocks that will see action this week
Here is what the charts say about the shares of Biocon, CONCOR and L&T Technology Services
